Literature DB >> 23736916

Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals.

Sheila F O'Brien1, Samra Uzicanin2, Karine Choquet2, Qi-Long Yi1, Wenli Fan2, Mindy Goldman3.   

Abstract

BACKGROUND: Travel to malaria risk areas such as Mexico is a common source of donor deferral in Canada. On February 21st, 2011 the deferrable regions in Mexico were revised to permit donation if donors travelled to the state of Quintana Roo, Mexico, a popular ocean-side resort area.
MATERIALS AND METHODS: Canadian travel data and malaria deferral rates since 2007 were plotted to examine trends. Deferral records in one centre were accessed from January to April, 2011 to tabulate travel destinations of deferred donors immediately before and after the change.
RESULTS: Travel to Mexico and the Caribbean accounts for 63% of general population travel, and travel to Mexico has been increasing (P <0.05). Deferral for short-term malaria risk travel has a strong seasonal trend with peaks in the winter and troughs in the summer. Approximately 36,000 fewer donations were lost following the change, a reduction of 37% from the previous year. Deferrals in one centre increased for Caribbean/Central America after the change (P <0.05) consistent with the seasonal trend, but decreased for Mexico (P <0.05). DISCUSSION: Deferrals for malaria risk travel are substantial. Careful revision and refinement of risk areas of travel can significantly reduce the burden of deferral.

Entities:  

Mesh:

Year:  2013        PMID: 23736916      PMCID: PMC3827404          DOI: 10.2450/2013.0261-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  12 in total

1.  Transfusion-transmitted malaria in Canada.

Authors:  R Slinger; A Giulivi; M Bodie-Collins; F Hindieh; R S John; G Sher; M Goldman; M Ricketts; K C Kain
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Transfusion-transmitted malaria in the United States from 1963 through 1999.

Authors:  M Mungai; G Tegtmeier; M Chamberland; M Parise
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 3.  Malaria and blood transfusion.

Authors:  A D Kitchen; P L Chiodini
Journal:  Vox Sang       Date:  2006-02       Impact factor: 2.144

4.  The use of malaria antibody tests in the prevention of transfusion-transmitted malaria.

Authors:  H W Reesink; S Panzer; S Wendel; J E Levi; H Ullum; S Ekblom-Kullberg; E Seifried; M Schmidt; E Shinar; D Prati; A Berzuini; S Ghosh; Ø Flesland; S Jeansson; E Zhiburt; M Piron; S Sauleda; B Ekermo; R Eglin; A Kitchen; R Y Dodd; D A Leiby; L M Katz; S Kleinman
Journal:  Vox Sang       Date:  2010-01-28       Impact factor: 2.144

5.  Malaria surveillance--United States, 2010.

Authors:  Sonja Mali; S Patrick Kachur; Paul M Arguin
Journal:  MMWR Surveill Summ       Date:  2012-03-02

6.  The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria.

Authors:  C R Seed; A Cheng; T M E Davis; W V Bolton; A J Keller; A Kitchen; T J Cobain
Journal:  Vox Sang       Date:  2005-02       Impact factor: 2.144

7.  Malaria surveillance--United States, 2009.

Authors:  Sonja Mali; Kathrine R Tan; Paul M Arguin
Journal:  MMWR Surveill Summ       Date:  2011-04-22

8.  Risk for malaria in United States donors deferred for travel to malaria-endemic areas.

Authors:  Bryan Spencer; Whitney Steele; Brian Custer; Steven Kleinman; Ritchard Cable; Susan Wilkinson; David Wright
Journal:  Transfusion       Date:  2009-11       Impact factor: 3.157

9.  Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.

Authors:  Sheila F O'brien; Jo Anne Chiavetta; Mindy Goldman; Wenli Fan; Rama C Nair; Graham D Sher; Eleftherios C Vamvakas
Journal:  Transfusion       Date:  2006-03       Impact factor: 3.157

10.  Impact of donor deferrals for malaria on blood availability in the United States.

Authors:  David A Leiby; Megan L Nguyen; Edward P Notari
Journal:  Transfusion       Date:  2008-07-30       Impact factor: 3.157

View more
  5 in total

1.  Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.

Authors:  Christoph Niederhauser; Jochen Gottschalk; Caroline Tinguely
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

2.  Post-exposure serological responses to malaria parasites in potential blood donors.

Authors:  Daniela Portugal-Calisto; Ana Raquel Ferreira; Marcelo Sousa Silva; Rosa Teodósio
Journal:  Malar J       Date:  2016-11-09       Impact factor: 2.979

Review 3.  Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas.

Authors:  Regina M Alho; Kim Vinícius Amaral Machado; Fernando F A Val; Nelson A Fraiji; Marcia A A Alexandre; Gisely C Melo; Judith Recht; André M Siqueira; Wuelton M Monteiro; Marcus V G Lacerda
Journal:  Malar J       Date:  2017-02-15       Impact factor: 2.979

Review 4.  Transfusion-Transmitted Malaria and Mitigation Strategies in Nonendemic Regions.

Authors:  Christoph Niederhauser; Susan A Galel
Journal:  Transfus Med Hemother       Date:  2022-07-15       Impact factor: 4.040

5.  Modelling the risk of transfusion transmission from travelling donors.

Authors:  Tonderai Mapako; Welling Oei; Marinus van Hulst; Mirjam E Kretzschmar; Mart P Janssen
Journal:  BMC Infect Dis       Date:  2016-04-01       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.